MedDevices AI
By
Can Ambience Healthcare’s $243M Series C Push the AI Scribing Market Toward a $5B Future?
Key Highlights Record Funding and Unicorn StatusAmbience Healthcare, founded in 2020 in San Francisco, announced a $243 million…
Will CMS’s 2026 WISeR AI Pilot Shift Traditional Medicare’s Access—How Might Algorithmic Prior Authorizations Reshape Patient Outcomes for 30 Million Seniors?
Key Highlights: AI-Powered Prior Authorization: New Model and ScopeCMS’s WISeR (Wasteful and Inappropriate Service Reduction) program introduces AI…
Is Illinois’ Ban on AI in Mental Healthcare a Turning Point for Human-Centered Therapy Regulation in the U.S.?
Key Highlights Background and Impetus for the BanDriven by incidents where AI chatbots posed risks—including cases suggesting harmful…
Can Zimmer Biomet’s $177 Million AI-Driven Acquisition of Monogram Technologies Redefine the Future of Autonomous Orthopedic Surgery by 2027?
Key Highlights Strategic Acquisition Enhances Zimmer Biomet’s Robotics LeadershipZimmer Biomet’s acquisition of Monogram Technologies, announced in July 2025,…
Can BD’s Expanded Recall of Alaris™ Pump Infusion Sets Trigger a Turning Point in Medical Device Safety Standards?
Key Insights BD’s updated recall follows internal testing that revealed infusion performance deviations, including flow rate accuracy issues,…
Can Johnson & Johnson’s Pact with Pacira BioSciences Redefine Early Intervention for Knee Osteoarthritis?
Key Insights Expanding Non-Surgical Pathways Through this agreement, Johnson & Johnson MedTech integrates ZILRETTA® into its Early Intervention…
